.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Management of Myelomeningocele Study randomized women carrying fetuses with open spina bifida to prenatal surgery or standard postnatal repair. Prenatal surgery reduced the need for ventriculoperitoneal shunt placement and improved motor-function-related outcomes at 30 months, although maternal and obstetric complications were increased. The study established fetal surgery as a potential option for carefully selected pregnancies in experienced centers. For HCPs, the central lesson is that fetal therapy involves a complex maternal-fetal risk trade-off rather than a simple fetal benefit. Counseling requires detailed imaging, multidisciplinary assessment, evaluation of gestational age and lesion characteristics, and discussion of maternal risks including uterine complications and preterm birth. The MOMS trial provides a classic example of how innovation can change outcomes while simultaneously creating new procedural and ethical considerations.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Management of Myelomeningocele Study randomized women carrying fetuses with open spina bifida to prenatal surgery or standard postnatal repair. Prenatal surgery reduced the need for ventriculoperitoneal shunt placement and improved motor-function-related outcomes at 30 months, although maternal and obstetric complications were increased. The study established fetal surgery as a potential option for carefully selected pregnancies in experienced centers. For HCPs, the central lesson is that fetal therapy involves a complex maternal-fetal risk trade-off rather than a simple fetal benefit. Counseling requires detailed imaging, multidisciplinary assessment, evaluation of gestational age and lesion characteristics, and discussion of maternal risks including uterine complications and preterm birth. The MOMS trial provides a classic example of how innovation can change outcomes while simultaneously creating new procedural and ethical considerations.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
